Tulsa, OK, United States of America

Charles Justin Van De Wiele

This inventor holds 1 USPTO granted patent. Top assignees: Oklahoma Medical Research Foundation, University of Oklahoma. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Justin Van De Wiele. Retrieved from https://idiyas.com/inventor/charles-justin-van-de-wiele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Charles Justin Van De Wiele

Introduction

Charles Justin Van De Wiele is an accomplished inventor based in Tulsa, OK. He has made significant contributions to the field of medical research, particularly in enhancing progenitor cell numbers for immune system therapies. His innovative work has the potential to impact the treatment of various immune-related conditions.

Latest Patents

Van De Wiele holds a patent for "Enhancing progenitor cell numbers - Therapies using IL-18 alone or in combination with IL-7 for rebuilding weakened immune systems by increasing progenitor cell yields from bone marrow stem cells and/or increasing stem cell engraftment in bone marrow." This patent represents a crucial advancement in regenerative medicine and immunotherapy.

Career Highlights

Throughout his career, Van De Wiele has worked with notable institutions such as the University of Oklahoma and the Oklahoma Medical Research Foundation. His research has focused on improving the efficacy of stem cell therapies, which can lead to better outcomes for patients with compromised immune systems.

Collaborations

Some of his coworkers include Tracy Kent Teague and Jonathan Wren. Their collaborative efforts have contributed to the advancement of research in the field of immunology and regenerative medicine.

Conclusion

Charles Justin Van De Wiele's innovative work in enhancing progenitor cell numbers showcases his dedication to improving medical therapies. His contributions have the potential to significantly benefit patients with weakened immune systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…